Weighted Average Number of Shares Outstanding, Diluted of ZEVRA THERAPEUTICS, INC. from 30 Jun 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ZEVRA THERAPEUTICS, INC. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2015 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 55,951,572, a 17% increase year-over-year.
  • ZEVRA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 57,262,715, a 24% increase from 2024.
  • ZEVRA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 46,251,239.
  • ZEVRA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 29,766,347, a 648% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 57,262,715 +11,011,476 +24% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 46,251,239 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2021 29,766,347 +25,785,372 +648% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022 2021 FY
2020 3,980,975 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY

ZEVRA THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 55,951,572 +8,142,755 +17% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 56,324,903 +14,425,816 +34% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 47,808,817 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 41,899,087 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q3 2021 35,217,953 +30,792,479 +696% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 29,174,565 +25,226,837 +639% 01 Apr 2021 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q3 2020 4,425,474 -27,246,675 -86% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 3,947,728 -24,438,391 -86% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q3 2019 31,672,149 +15,638,226 +98% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 28,386,119 +11,837,368 +72% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q3 2018 16,033,923 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 16,548,751 +1,899,165 +13% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q2 2017 14,649,586 -785,736 -5.1% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q2 2016 15,435,322 +3,277,808 +27% 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q2 2015 12,157,514 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.